The use of the Oxford/AstraZeneca vaccine in Denmark has been suspended in what is being described as a “precautionary” move after one person has died with blood clots after taking the jab. The European drugs watchdog is now set to investigate. Soren Brostrom is the head of the Danish health authority. He said: “Right now we need all the vaccines we can get. Therefore, pausing one of the vaccines is not an easy decision”. Mr Brostrom was keen to state that the act has been taken based on the “precautionary principle.
Those who have had the jab in the past two weeks will receive a letter from health authorities alerting them to the signs of blood clots and asking them to contact their doctors if they suffer any of those symptoms.
Austria had also suspended use but on o Wednesday, the European Medicines Agency said there was no “specific issue” with the batch used in Austria. In this batch two clotting cases, which included one death had been reported after vaccination. The EMA has said: “There is currently no indication that vaccination has caused these conditions, which are not listed as side effects with this vaccine”.
In Europe, the European Commission has said that it will follow the lead of the EMA. Danish health authorities have said that if they no longer use the AstraZeneca vaccines at all, then they will not be able to vaccinate their adult population until mid-August which is a month later than their previous forecast.
Current Affairs Correspondent | My name is Oliver Down I am 22, and a staunch brexiteer. I am a Bristolian lad who studied politics in Leicester. I believe in free speech and accurate journalism and I won’t be afraid to give you “the other side” of the story!
[sibwp_form id=4]
